Assessing the global implications of the COVID-19 pandemic on the cervical cancer elimination initiative
Open Access
- 28 April 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (4) , e0004419
Abstract
The COVID-19 pandemic disrupted many public health programs; understanding these disruptions is critical for directing future resources. In a project studying the implementation of human papillomavirus (HPV) testing-based cervical cancer screening, we queried about the impact of the pandemic on screening programs globally. In consultation with World Health Organization’s Regional Advisors, program managers, government officials, and clinicians involved in the implementation of HPV testing-based cervical cancer screening programs were invited to participate in semi-structured, in-depth, interviews. Interview notes and transcripts were used for inductive analysis, focusing on responses to the impact of COVID-19 pandemic on screening programs. Thirty-two interviews were conducted with participants between the age of 29 and 61 years, representing programs from 25 countries. Six key themes were noted. Regarding disruptions, (1) the entire cancer continuum was affected, leading to delays or, in some cases even cessation of vaccination, screening, and treatment programs; and (2) a heightened sense of fear around contracting and transmitting COVID-19 shifted government priorities and impacted healthcare delivery. Nonetheless, participants noted constructive ways in which programs leveraged the impact of the pandemic: (1) at the community level, participants were able to leverage an increased understanding and acceptance surrounding the importance of preventive health behaviors; (2) for HPV-testing: molecular laboratories became well-equipped with better technician training, increasing overall HPV-testing capacities; (3) the pandemic promoted virtual healthcare systems; and (4) for planning: shutdowns allowed time to plan for program scale-up. In many ways, the pandemic response provided evidence supporting countries’ abilities to mobilize resources. While disruptions were noted, the pandemic provided implementers with opportunities to strengthen screening programs, which should be further assessed in future sustainability research on cervical cancer prevention and control.Keywords
Funding Information
- World Health Organization (202833289)
- National Cancer Institute (75N91019D00024)
This publication has 22 references indexed in Scilit:
- The recovery strategies to support cervical cancer elimination in lower-and middle-income countries (LMICs) following COVID-19 disruptionsPreventive Medicine Reports, 2023
- Delivery of Cervical and Colorectal Cancer Screenings During the Pandemic in Community Health CentersMedical Care, 2023
- Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination InitiativeThe Lancet Global Health, 2022
- Prevention, diagnosis and treatment of cervical cancer: A systematic review of the impact of COVID-19 on patient carePreventive Medicine, 2022
- Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 surveyPreventive Medicine, 2021
- Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparitiesPreventive Medicine, 2021
- Interruption of cancer screening services due to COVID-19 pandemic: lessons from previous disastersPreventive Medicine Reports, 2021
- Applying Lessons Learned From Low-Resource Settings to Prioritize Cancer Care in a PandemicJAMA Oncology, 2020
- Comparison of HPV prevalence between HPV-vaccinated and non-vaccinated young adult women (20–26 years)Human Vaccines & Immunotherapeutics, 2015
- Advancing a Conceptual Model of Evidence-Based Practice Implementation in Public Service SectorsAdministration and Policy in Mental Health and Mental Health Services Research, 2010